Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about REGN
Recent news which mentions REGN
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
32
33
Next >
Earnings Scheduled For November 2, 2023
November 02, 2023
Tickers
RCM
RDFN
REFR
REG
Tags
SWN
RLAY
RKT
From
Benzinga
Regeneron Pharmaceuticals Unusual Options Activity
November 01, 2023
Tickers
REGN
Tags
BZI/UOA
Options
Markets
From
Benzinga
$100 Invested In Regeneron Pharmaceuticals 15 Years Ago Would Be Worth This Much Today
October 31, 2023
Tickers
REGN
Tags
Trading Ideas
News
Market News
From
Benzinga
MAIA Biotechnology Reports Positive Phase 2 Clinical Trial Data On Its Treatment For Non-Small Cell Lung Cancer
October 30, 2023
Tickers
MAIA
REGN
Tags
REGN
MAIA Biotechnology Inc/
Penny Stocks
From
Benzinga
Gene Therapy Could Be On the Cusp of a Major Breakthrough, but Investors May Have to Remain Patient
October 30, 2023
Tickers
AMGN
BLUE
CRSP
EDIT
Tags
VRTX
BLUE
EDIT
From
Motley Fool
Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week
October 30, 2023
Tickers
AAPL
ADM
AGYS
AJG
Tags
BHC
PARA
LLY
From
Benzinga
Are Your Eyes At Grave Risk? FDA Issues Dangerous Warning Over Popular Drops From CVS, Target, Cardinal Health And More
October 28, 2023
Tickers
BHC
CAH
CVS
NVS
Tags
TGT
CVS
BHC
From
Benzinga
SNY Stock Sinks 15% as Sanofi Plans Consumer Unit Spinoff
October 27, 2023
Tickers
JNJ
KVUE
PFE
REGN
Tags
SNY
Market News
KVUE
From
InvestorPlace
Stock-Split Watch: Could These 2 Growth Stocks Be Next?
October 25, 2023
Tickers
BKNG
REGN
Tags
Market News
REGN
BKNG
From
Motley Fool
Which Is the Better Long-Term Hold for Investors: Pfizer or Roche?
October 21, 2023
Tickers
BMY
BNTX
PFE
REGN
Tags
BNTX
BMY
PFE
From
Motley Fool
$100 Invested In This Stock 20 Years Ago Would Be Worth $6,000 Today
October 19, 2023
Tickers
REGN
Tags
Trading Ideas
News
Market News
From
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
October 18, 2023
Tickers
AMGN
AMLX
APLS
CNC
Tags
Benzinga
Market News
CNC
From
Benzinga
Price Over Earnings Overview: Regeneron Pharmaceuticals
October 17, 2023
Tickers
REGN
Tags
REGN
Market News
Benzinga
From
Benzinga
Cantor Fitzgerald Maintains Neutral Rating for Regeneron Pharmaceuticals: Here's What You Need To Know
October 16, 2023
Tickers
REGN
Tags
REGN
BZI/AAR/UPDATE
Analyst Ratings
From
Benzinga
2 Healthcare Stocks Near 52-Week Highs Still Worth Buying
October 16, 2023
Tickers
BAYN
NTLA
REGN
SNY
Tags
VRTX
NTLA
Recent Press Releases
From
Motley Fool
Sanofi reaps rewards of immunology investment with eczema results
October 13, 2023
Tickers
AMGN
KYKOY
REGN
SNY
Tags
REGN
AMGN
KYKOY
From
MarketWatch
The Latest Analyst Ratings for Regeneron Pharmaceuticals
October 11, 2023
Tickers
REGN
Tags
Analyst Ratings
REGN
BZI/AAR
From
Benzinga
Down 45%, Is Intellia a Buy?
October 10, 2023
Tickers
NTLA
REGN
Tags
REGN
Recent Press Releases
NTLA
From
Motley Fool
P/E Ratio Insights for Regeneron Pharmaceuticals
October 06, 2023
Tickers
REGN
Tags
Markets
News
Intraday Update
From
Benzinga
This Market-Beating Stock Just Gave Investors More Reasons to Invest
October 05, 2023
Tickers
REGN
Tags
Market News
REGN
Recent Press Releases
From
Motley Fool
Here's the Best Big Pharma Stock of the Decade so Far (and It's Not Even Close)
October 05, 2023
Tickers
LLY
NVO
REGN
Tags
REGN
Recent Press Releases
NVO
From
Motley Fool
$100 Invested In This Stock 5 Years Ago Would Be Worth $200 Today
October 04, 2023
Tickers
REGN
Tags
News
Earnings
BZI/POD
From
Benzinga
MAIA Secures FDA Clearance Of IND Application For THIO For Non-Small Cell Lung Cancer
October 03, 2023
Tickers
MAIA
REGN
Tags
Markets
News
Equities
From
Benzinga
Regeneron Pharmaceuticals Unusual Options Activity
October 03, 2023
Tickers
REGN
Tags
Market News
Benzinga
BZI/UOA
From
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
October 02, 2023
Tickers
ACAD
BGNE
ICPT
IMCR
Tags
Benzinga
Market News
OGN
From
Benzinga
Stock Split Watch: Is Regeneron Pharmaceuticals Next?
September 30, 2023
Tickers
AMZN
REGN
SNY
TSLA
Tags
TSLA
Market News
SNY
From
Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
September 28, 2023
Tickers
ALGN
BBIO
BCLI
CVS
Tags
ALGN
Benzinga
Market News
From
Benzinga
Analyst Expectations for Regeneron Pharmaceuticals's Future
September 21, 2023
Tickers
REGN
Tags
Benzinga
Market News
BZI/AAR
From
Benzinga
This Recent FDA Approval Could Give Regeneron's Top Line a Big Boost
September 20, 2023
Tickers
REGN
Tags
Market News
REGN
Recent Press Releases
From
Motley Fool
3 Stocks to Buy to Ride Europe’s Coming Market Surge
September 19, 2023
Tickers
BAC
EUDV
JPM
NGG
Tags
REGN
SNY
Market News
From
InvestorPlace
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today